Systemic tissue repair — accelerates healing of muscle, tendon, heart, and eye tissue.
TB-500 is a synthetic peptide fragment of Thymosin Beta-4 — a naturally occurring protein found in virtually all human and animal cells. It plays a critical role in cell migration, survival, and differentiation. TB-500 is used for systemic healing and recovery from injury.
Mechanism: TB-500 acts primarily by upregulating actin — the protein that forms the cellular cytoskeleton. By regulating actin polymerization, TB-500 promotes cell migration to injury sites, reduces inflammation, and accelerates tissue repair across multiple tissue types simultaneously.
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Loading (acute injury) | 2.5 mg | 2× per week | 4–6 weeks |
| Loading (general) | 2 mg | 2× per week | 4–6 weeks |
| Maintenance | 1.25–2 mg | 1× per week | Ongoing |
| Low-dose preventive | 1 mg | 1× per week | Ongoing |
Loading phase: 2–2.5 mg SubQ twice per week (e.g., Monday and Thursday) for 4–6 weeks. Then drop to maintenance: 1.25–2 mg once per week. TB-500's longer half-life (~3 days) means twice-weekly dosing provides consistent blood levels throughout the loading phase. Unlike BPC-157, TB-500 is systemic — injection site does not need to be near the injury.